Aakaar Medical Technologies Financials
NSE: AAKAAR
₹62.70
As on 04-Sep-2026 15:32IST
Market cap
₹89 Cr
Revenue (TTM)
₹67 Cr
P/E Ratio
13.4
P/B Ratio
1.6
Div. Yield
0 %
Income Statement (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
66.96
|
61.58
|
46.11
|
32.78
|
19.47
|
--
|
|||||
|
Total Income
|
67.77
|
61.76
|
46.27
|
32.88
|
19.51
|
--
|
|||||
|
Total Expenditure
|
56.65
|
51.81
|
41.11
|
29.26
|
17.07
|
--
|
|||||
|
EBITDA
|
10.31
|
9.77
|
5.00
|
3.53
|
2.40
|
--
|
|||||
|
Depreciation
|
0.13
|
0.12
|
0.14
|
0.09
|
0.02
|
--
|
|||||
|
EBIT
|
10.18
|
9.65
|
4.86
|
3.44
|
2.37
|
--
|
|||||
|
Interest
|
1.80
|
1.71
|
1.14
|
0.43
|
0.21
|
--
|
|||||
|
Other Income
|
0.80
|
0.18
|
0.16
|
0.09
|
0.04
|
--
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
9.19
|
8.11
|
3.89
|
3.10
|
2.20
|
--
|
|||||
|
Provision for Tax
|
2.55
|
2.08
|
1.02
|
0.95
|
0.59
|
--
|
|||||
|
Profit after Tax
|
6.64
|
6.03
|
2.87
|
2.15
|
1.62
|
--
|
Liabilities (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
54.55
|
23.26
|
12.54
|
9.66
|
8.03
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
0.51
|
2.48
|
1.59
|
0.40
|
0.32
|
--
|
|||||
|
Current Liabilities
|
23.90
|
30.04
|
20.64
|
12.91
|
9.45
|
--
|
|||||
|
Total Liabilities
|
79.44
|
56.16
|
35.12
|
23.23
|
18.00
|
--
|
Assets (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
2.33
|
3.85
|
1.96
|
0.75
|
0.47
|
--
|
|||||
|
Current Assets
|
76.63
|
51.91
|
32.81
|
22.22
|
17.33
|
--
|
|||||
|
Total Assets
|
79.44
|
56.16
|
35.12
|
23.23
|
18.00
|
--
|
|||||
|
Total Debt*
|
18.53
|
22.74
|
15.06
|
5.87
|
3.82
|
--
|
|||||
|
Net Current Assets
|
52.73
|
21.88
|
12.17
|
9.32
|
7.88
|
--
|
|||||
|
Contingent Liabilities
|
--
|
--
|
0.61
|
--
|
--
|
--
|
Cashflow (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-8.36
|
-5.41
|
-8.04
|
-2.93
|
0.48
|
--
|
|||||
|
Cash Flow from Investing Activities
|
0.05
|
-0.05
|
-0.04
|
-0.32
|
-0.23
|
--
|
|||||
|
Cash from Financing Activities
|
18.80
|
10.71
|
8.19
|
1.17
|
-0.81
|
--
|
|||||
|
Net Cash Inflow / Outflow
|
10.48
|
5.25
|
0.11
|
-2.08
|
-0.55
|
--
|
Financials Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
4.68
|
5.79
|
3.00
|
2.25
|
1.69
|
--
|
|||||
|
Cash EPS (₹)
|
4.77
|
5.91
|
3.15
|
2.35
|
1.72
|
--
|
|||||
|
Adjusted Book Value (₹)
|
38.49
|
22.32
|
13.11
|
10.11
|
8.40
|
--
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
0.55
|
0.59
|
--
|
|||||
|
Cash Flow per Share (₹)
|
-5.90
|
-5.19
|
-114.92
|
-41.82
|
6.92
|
--
|
|||||
|
Free Cash Flow per Share (₹)
|
-7.34
|
-6.76
|
-125.38
|
-54.93
|
2.85
|
--
|
Profitability Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
18.45
|
26.69
|
23.29
|
25.81
|
20.40
|
--
|
|||||
|
ROE (%)
|
17.06
|
33.72
|
25.88
|
24.35
|
20.16
|
--
|
|||||
|
ROA (%)
|
9.85
|
13.33
|
9.94
|
10.56
|
9.09
|
--
|
|||||
|
EBIT Margin (%)
|
15.21
|
15.66
|
10.55
|
10.49
|
12.19
|
--
|
|||||
|
Net Margin (%)
|
9.79
|
9.77
|
6.20
|
6.55
|
8.30
|
--
|
|||||
|
Cash Profit Margin (%)
|
10.10
|
10.00
|
6.52
|
6.84
|
8.43
|
--
|
Growth Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
8.74
|
33.55
|
40.65
|
68.43
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
5.58
|
98.32
|
41.41
|
44.89
|
--
|
--
|
|||||
|
Net Profit Growth (%)
|
10.03
|
110.18
|
33.30
|
33.04
|
--
|
--
|
|||||
|
EPS Growth (%)
|
-19.09
|
92.69
|
33.30
|
33.04
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
134.54
|
85.69
|
29.73
|
20.28
|
--
|
--
|
Valuation Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
10.27
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
1.25
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
6.34
|
2.78
|
3.00
|
1.76
|
0.92
|
--
|
|||||
|
Close Price (₹)
|
48.10
|
--
|
--
|
--
|
--
|
--
|
|||||
|
High Price (₹)
|
105.00
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Low Price (₹)
|
46.00
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Market Cap (₹ Cr)
|
68.17
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.34
|
0.98
|
1.20
|
0.61
|
0.48
|
--
|
|||||
|
Short term debt to equity ratio
|
0.34
|
0.98
|
1.20
|
0.61
|
0.48
|
--
|
|||||
|
Current Ratio
|
3.21
|
1.73
|
1.59
|
1.72
|
1.83
|
--
|
|||||
|
Quick Ratio
|
2.38
|
1.24
|
0.90
|
0.85
|
1.09
|
--
|
|||||
|
Interest Coverage
|
6.12
|
5.75
|
4.42
|
8.21
|
11.32
|
--
|
Operating Efficiency Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
55.59
|
45.47
|
35.27
|
31.21
|
28.62
|
--
|
|||||
|
Asset Turnover
|
0.99
|
1.36
|
1.60
|
1.61
|
1.09
|
--
|
|||||
|
Receivable days
|
177.77
|
131.18
|
104.87
|
87.97
|
104.45
|
--
|
|||||
|
Inventory Days
|
93.49
|
85.15
|
100.66
|
101.60
|
131.22
|
--
|
|||||
|
Payable days
|
34.92
|
37.08
|
37.89
|
50.42
|
65.10
|
--
|
|||||
|
Cash Conversion Cycle
|
236.35
|
179.26
|
167.64
|
139.15
|
170.57
|
--
|